Mirum Pharmaceuticals Stock Market Value
| MIRM Stock | USD 46.65 1.50 3.32% |
| Symbol | Mirum |
Mirum Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mirum Pharmaceuticals. If investors know Mirum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mirum Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.08) | Revenue Per Share 6.513 | Quarterly Revenue Growth 0.894 | Return On Assets (0.09) | Return On Equity (0.40) |
The market value of Mirum Pharmaceuticals is measured differently than its book value, which is the value of Mirum that is recorded on the company's balance sheet. Investors also form their own opinion of Mirum Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Mirum Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mirum Pharmaceuticals' market value can be influenced by many factors that don't directly affect Mirum Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mirum Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mirum Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mirum Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Mirum Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Mirum Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Mirum Pharmaceuticals.
| 10/30/2024 |
| 11/29/2024 |
If you would invest 0.00 in Mirum Pharmaceuticals on October 30, 2024 and sell it all today you would earn a total of 0.00 from holding Mirum Pharmaceuticals or generate 0.0% return on investment in Mirum Pharmaceuticals over 30 days. Mirum Pharmaceuticals is related to or competes with Immunocore Holdings, Larimar Therapeutics, Kalvista Pharmaceuticals, Lyra Therapeutics, Terns Pharmaceuticals, Amylyx Pharmaceuticals, and Acumen Pharmaceuticals. Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel ther... More
Mirum Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Mirum Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Mirum Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.51 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 12.25 | |||
| Value At Risk | (4.31) | |||
| Potential Upside | 3.88 |
Mirum Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mirum Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Mirum Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Mirum Pharmaceuticals historical prices to predict the future Mirum Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0412 | |||
| Jensen Alpha | 0.016 | |||
| Total Risk Alpha | (0.27) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.1374 |
Mirum Pharmaceuticals Backtested Returns
Mirum Pharmaceuticals appears to be very steady, given 3 months investment horizon. Mirum Pharmaceuticals has Sharpe Ratio of 0.0937, which conveys that the firm had a 0.0937% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Mirum Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please exercise Mirum Pharmaceuticals' Mean Deviation of 1.79, downside deviation of 2.51, and Risk Adjusted Performance of 0.0412 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Mirum Pharmaceuticals holds a performance score of 7. The company secures a Beta (Market Risk) of 0.73, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Mirum Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Mirum Pharmaceuticals is expected to be smaller as well. Please check Mirum Pharmaceuticals' value at risk, as well as the relationship between the skewness and day median price , to make a quick decision on whether Mirum Pharmaceuticals' current price movements will revert.
Auto-correlation | 0.36 |
Below average predictability
Mirum Pharmaceuticals has below average predictability. Overlapping area represents the amount of predictability between Mirum Pharmaceuticals time series from 30th of October 2024 to 14th of November 2024 and 14th of November 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Mirum Pharmaceuticals price movement. The serial correlation of 0.36 indicates that just about 36.0% of current Mirum Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.36 | |
| Spearman Rank Test | 0.53 | |
| Residual Average | 0.0 | |
| Price Variance | 2.71 |
Mirum Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Mirum Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Mirum Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Mirum Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Mirum Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Mirum Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Mirum Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Mirum Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Mirum Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Mirum Pharmaceuticals Lagged Returns
When evaluating Mirum Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Mirum Pharmaceuticals stock have on its future price. Mirum Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Mirum Pharmaceuticals autocorrelation shows the relationship between Mirum Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Mirum Pharmaceuticals.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Mirum Pharmaceuticals Correlation, Mirum Pharmaceuticals Volatility and Mirum Pharmaceuticals Alpha and Beta module to complement your research on Mirum Pharmaceuticals. To learn how to invest in Mirum Stock, please use our How to Invest in Mirum Pharmaceuticals guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Mirum Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.